Product Information

BUSPIRONE HCL 5 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.0217 per EA under NDC 72888006201. Its NADAC has been published 218 times since Sep 21, 2022.

FDA first approved this application on Apr 5, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUSPIRONE HCL 5 MG TABLET

buspirone hydrochloride
$0.0217per EA

Strength

5 mg/1

NDC

72888006201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

BUSPIRONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075521

FDA Approved

4/5/2002

TE Code

AB

On Market Since

12/29/2020

Price Statistics

The NADAC for BUSPIRONE HCL 5 MG TABLET has been published 218 times since Sep 21, 2022, and over the history we have for it it has declined 22.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0217 per EA
All-time high$0.0314 (Nov 16, 2022)
All-time low$0.0174 (Nov 20, 2024)
52-week high$0.0221
52-week low$0.0216
Median price$0.0232
Average price$0.0238
Largest weekly change-25.2% (Nov 20, 2024)
Weeks tracked218
Tracking sinceSep 21, 2022

Price History

1W

-0.5%

1M

-1.0%

3M

-0.1%

6M

-1.4%

1Y

+1.4%

3Y

-13.0%

5Y

N/A

All

-22.7%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUSPIRONE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 5 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.0217 per EA (NDC 72888006201), effective Nov 18, 2026.

How has the price of BUSPIRONE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUSPIRONE HCL 5 MG TABLET has declined 22.7%. It has been tracked across 218 weekly CMS publications since Sep 21, 2022.

What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 5 MG TABLET?

Since Sep 21, 2022, the NADAC for BUSPIRONE HCL 5 MG TABLET has ranged from a low of $0.0174 (Nov 20, 2024) to a high of $0.0314 (Nov 16, 2022), with a median of $0.0232 per EA.

Are there cheaper alternatives to BUSPIRONE HCL 5 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUSPIRONE HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUSPIRONE HCL 5 MG TABLET?

BUSPIRONE HCL 5 MG TABLET (NDC 72888006201) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.